This new 260-page report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.  The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.During the next five years, the abused drug testing market will undergo significant transformation.  These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.  Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology.  This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.“2015-2019 Japanese Drugs of Abuse Testing Market: Hospitals and Commercial Labs” is a unique study designed to help current suppliers and potential market... Research Beam Model: Research Beam Product ID: 303129 0 USD New
2015-2019 Japanese Drugs of Abuse Testing Market: Hospitals and Commercial Labs-Competitive Strategies, Supplier Shares, Segment Forecasts, Innovative Technologies, Instrumentation Review

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

2015-2019 Japanese Drugs of Abuse Testing Market: Hospitals and Commercial Labs-Competitive Strategies, Supplier Shares, Segment Forecasts, Innovative Technologies, Instrumentation Review

 
  • Category : Diagnostic and Biotech
  • Published On : July  2015
  • Pages : 260
 
 

This new 260-page report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. 

The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.

During the next five years, the abused drug testing market will undergo significant transformation.  These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.  Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology.  This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

“2015-2019 Japanese Drugs of Abuse Testing Market: Hospitals and Commercial Labs” is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses.  The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.                                                     

Contains 260 pages and 10 tables